{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:36:36Z","timestamp":1783535796130,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G031915N"],"award-info":[{"award-number":["G031915N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12A3814N"],"award-info":[{"award-number":["12A3814N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["GENOMED"],"award-info":[{"award-number":["GENOMED"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["FFB190208"],"award-info":[{"award-number":["FFB190208"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["SYBIL"],"award-info":[{"award-number":["SYBIL"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602300"],"award-info":[{"award-number":["602300"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-023-01158-0","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T05:02:11Z","timestamp":1701752531000},"page":"171-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6715-9241","authenticated-orcid":false,"given":"Gretl","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4818-6804","authenticated-orcid":false,"given":"Eveline","family":"Boudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2655-3581","authenticated-orcid":false,"given":"Ligia","family":"Mateiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-0983","authenticated-orcid":false,"given":"Timur A.","family":"Yorgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Steenackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kneissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9871-4578","authenticated-orcid":false,"given":"Geert","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-0177","authenticated-orcid":false,"given":"Thorsten","family":"Schinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5065-7858","authenticated-orcid":false,"given":"Wim","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"1158_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fendo.2020.00165","volume":"11","author":"Y Huybrechts","year":"2020","unstructured":"Huybrechts Y, Mortier G, Boudin E, Van Hul W (2020) WNT signaling and bone: lessons from skeletal dysplasias and disorders. Front Endocrinol (Lausanne) 11:165","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1158_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jbmr.4715","volume":"38","author":"DJM Bergen","year":"2023","unstructured":"Bergen DJM, Maurizi A, Formosa MM, McDonald GLK, El-Gazzar A, Hassan N, Brandi ML, Riancho JA, Rivadeneira F, Ntzani E, Duncan EL, Gregson CL, Kiel DP, Zillikens MC, Sangiorgi L, Hogler W, Duran I, Makitie O, Van Hul W, Hendrickx G (2023) High bone mass disorders: new insights from connecting the clinic and the bench. J Bone Miner Res 38:229\u2013247","journal-title":"J Bone Miner Res"},{"key":"1158_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","volume":"63","author":"H Hamersma","year":"2003","unstructured":"Hamersma H, Gardner J, Beighton P (2003) The natural history of sclerosteosis. Clin Genet 63:192\u2013197","journal-title":"Clin Genet"},{"key":"1158_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537\u2013543","journal-title":"Hum Mol Genet"},{"key":"1158_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577\u2013589","journal-title":"Am J Hum Genet"},{"key":"1158_CR6","doi-asserted-by":"publisher","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","volume":"286","author":"O Leupin","year":"2011","unstructured":"Leupin O, Piters E, Halleux C, Hu S, Kramer I, Morvan F, Bouwmeester T, Schirle M, Bueno-Lozano M, Fuentes FJ, Itin PH, Boudin E, de Freitas F, Jennes K, Brannetti B, Charara N, Ebersbach H, Geisse S, Lu CX, Bauer A, Van Hul W, Kneissel M (2011) Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. J Biol Chem 286:19489\u201319500","journal-title":"J Biol Chem"},{"key":"1158_CR7","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/jbmr.474","volume":"26","author":"AH van Lierop","year":"2011","unstructured":"van Lierop AH, Hamdy NA, Hamersma H, van Bezooijen RL, Power J, Loveridge N, Papapoulos SE (2011) Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover. J Bone Miner Res 26:2804\u20132811","journal-title":"J Bone Miner Res"},{"key":"1158_CR8","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","volume":"23","author":"B Ohkawara","year":"2014","unstructured":"Ohkawara B, Cabrera-Serrano M, Nakata T, Milone M, Asai N, Ito K, Ito M, Masuda A, Ito Y, Engel AG, Ohno K (2014) LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner. Hum Mol Genet 23:1856\u20131868","journal-title":"Hum Mol Genet"},{"key":"1158_CR9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/jbmr.2782","volume":"31","author":"I Fijalkowski","year":"2016","unstructured":"Fijalkowski I, Geets E, Steenackers E, Van Hoof V, Ramos FJ, Mortier G, Fortuna AM, Van Hul W, Boudin E (2016) A novel domain-specific mutation in a sclerosteosis patient suggests a role of LRP4 as an anchor for sclerostin in human bone. J Bone Miner Res 31:874\u2013881","journal-title":"J Bone Miner Res"},{"key":"1158_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/genes13010080","volume":"13","author":"Y Huybrechts","year":"2022","unstructured":"Huybrechts Y, Boudin E, Hendrickx G, Steenackers E, Hamdy N, Mortier G, Martinez Diaz-Guerra G, Bracamonte MS, Appelman-Dijkstra NM, Van Hul W (2022) Identification of compound heterozygous variants in LRP4 demonstrates that a pathogenic variant outside the third beta-propeller domain can cause sclerosteosis. Genes (Basel) 13:80","journal-title":"Genes (Basel)"},{"key":"1158_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007930","volume":"4","author":"HY Choi","year":"2009","unstructured":"Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS ONE 4:e7930","journal-title":"PLoS ONE"},{"key":"1158_CR12","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1073\/pnas.1419714112","volume":"112","author":"L Xiong","year":"2015","unstructured":"Xiong L, Jung JU, Wu H, Xia WF, Pan JX, Shen C, Mei L, Xiong WC (2015) Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. Proc Natl Acad Sci USA 112:3487\u20133492","journal-title":"Proc Natl Acad Sci USA"},{"key":"1158_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1359\/jbmr.090730","volume":"25","author":"I Kramer","year":"2010","unstructured":"Kramer I, Loots GG, Studer A, Keller H, Kneissel M (2010) Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res 25:178\u2013189","journal-title":"J Bone Miner Res"},{"key":"1158_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1359\/jbmr.080216","volume":"23","author":"X Li","year":"2008","unstructured":"Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D\u2019Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23:860\u2013869","journal-title":"J Bone Miner Res"},{"key":"1158_CR15","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/jbmr.3160","volume":"32","author":"E Boudin","year":"2017","unstructured":"Boudin E, Yorgan T, Fijalkowski I, Sonntag S, Steenackers E, Hendrickx G, Peeters S, De Mare A, Vervaet B, Verhulst A, Mortier G, D\u2019Haese P, Schinke T, Van Hul W (2017) The Lrp4R1170Q homozygous knock-in mouse recapitulates the bone phenotype of sclerosteosis in humans. J Bone Miner Res 32:1739\u20131749","journal-title":"J Bone Miner Res"},{"key":"1158_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.isci.2019.09.023","volume":"20","author":"WA Bullock","year":"2019","unstructured":"Bullock WA, Hoggatt AM, Horan DJ, Elmendorf AJ, Sato AY, Bellido T, Loots GG, Pavalko FM, Robling AG (2019) Lrp4 mediates bone homeostasis and mechanotransduction through interaction with sclerostin in vivo. iScience 20:205\u2013215","journal-title":"iScience"},{"key":"1158_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543","journal-title":"N Engl J Med"},{"key":"1158_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nrrheum.2015.48","volume":"11","author":"G Hendrickx","year":"2015","unstructured":"Hendrickx G, Boudin E, Van Hul W (2015) A look behind the scenes: the risk and pathogenesis of primary osteoporosis. Nat Rev Rheumatol 11:462\u2013474","journal-title":"Nat Rev Rheumatol"},{"key":"1158_CR19","doi-asserted-by":"publisher","first-page":"E5187","DOI":"10.1073\/pnas.1413828111","volume":"111","author":"MK Chang","year":"2014","unstructured":"Chang MK, Kramer I, Huber T, Kinzel B, Guth-Gundel S, Leupin O, Kneissel M (2014) Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels. Proc Natl Acad Sci USA 111:E5187-5195","journal-title":"Proc Natl Acad Sci USA"},{"key":"1158_CR20","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Hurst V, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol 18:e3000411","journal-title":"PLoS Biol"},{"key":"1158_CR21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/jbmr.2461","volume":"30","author":"TA Yorgan","year":"2015","unstructured":"Yorgan TA, Peters S, Jeschke A, Benisch P, Jakob F, Amling M, Schinke T (2015) The anti-osteoanabolic function of sclerostin is blunted in mice carrying a high bone mass mutation of Lrp5. J Bone Miner Res 30:1175\u20131183","journal-title":"J Bone Miner Res"},{"key":"1158_CR22","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468\u20131486","journal-title":"J Bone Miner Res"},{"key":"1158_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1083\/jcb.201207142","volume":"200","author":"J Albers","year":"2013","unstructured":"Albers J, Keller J, Baranowsky A, Beil FT, Catala-Lehnen P, Schulze J, Amling M, Schinke T (2013) Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J Cell Biol 200:537\u2013549","journal-title":"J Cell Biol"},{"key":"1158_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"1158_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007321","volume":"14","author":"G Hendrickx","year":"2018","unstructured":"Hendrickx G, Borra VM, Steenackers E, Yorgan TA, Hermans C, Boudin E, Waterval JJ, Jansen IDC, Aydemir TB, Kamerling N, Behets GJ, Plumeyer C, D\u2019Haese PC, Busse B, Everts V, Lammens M, Mortier G, Cousins RJ, Schinke T, Stokroos RJ, Manni JJ, Van Hul W (2018) Conditional mouse models support the role of SLC39A14 (ZIP14) in hyperostosis cranialis interna and in bone homeostasis. PLoS Genet 14:e1007321","journal-title":"PLoS Genet"},{"key":"1158_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"1158_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004092","volume":"3","author":"A Ohazama","year":"2008","unstructured":"Ohazama A, Johnson EB, Ota MS, Choi HY, Porntaveetus T, Oommen S, Itoh N, Eto K, Gritli-Linde A, Herz J, Sharpe PT (2008) Lrp4 modulates extracellular integration of cell signaling pathways in development. PLoS ONE 3:e4092","journal-title":"PLoS ONE"},{"key":"1158_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrrheum.2009.239","volume":"6","author":"E Ozcivici","year":"2010","unstructured":"Ozcivici E, Luu YK, Adler B, Qin YX, Rubin J, Judex S, Rubin CT (2010) Mechanical signals as anabolic agents in bone. Nat Rev Rheumatol 6:50\u201359","journal-title":"Nat Rev Rheumatol"},{"key":"1158_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.molmed.2009.03.001","volume":"15","author":"KK Papachroni","year":"2009","unstructured":"Papachroni KK, Karatzas DN, Papavassiliou KA, Basdra EK, Papavassiliou AG (2009) Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med 15:208\u2013216","journal-title":"Trends Mol Med"},{"key":"1158_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta JR, Wasserman SM, Katz L, Maddox J, Yang YC, Libanati C, Bone HG (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370:412\u2013420","journal-title":"N Engl J Med"},{"key":"1158_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jbmr.173","volume":"26","author":"D Padhi","year":"2011","unstructured":"Padhi D, Jang G, Stouch B, Fang L, Posvar E (2011) Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26:19\u201326","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-023-01158-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T15:05:48Z","timestamp":1705935948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-023-01158-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["1158"],"URL":"https:\/\/doi.org\/10.1007\/s00223-023-01158-0","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GH, EB, LM, TAY, ES, GM, TS and WVH declare that they have no conflict of interest. MK and IK are employees of Novartis Institutes for BioMedical Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All animal experimental procedures were carried out in compliance with the ARRIVE guidelines\u00a0and European Commission\u00a0Council Directive\u00a02010\/63\/EU on protecting animals for scientific purposes and\u00a0ethical approval for all procedures was obtained by the University of Antwerp Ethics Committee (Reference Number 2017-60).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All animal experimental procedures were carried out in compliance with the ARRIVE guidelines and were approved by the University of Antwerp Ethics Committee (reference number 2017-60).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"No informed consent statement.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}